細胞培養培地の市場規模、シェア、成長分析、タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

細胞培養培地の世界市場規模は、2022年に52億米ドルと評価され、2023年の62億3,000万米ドルから2031年には204億5,000万米ドルに成長し、予測期間中（2024-2031年）のCAGRは16.02％で成長する見通しです。

同市場は、新たな伝染病の増加により、今後も成長すると予測されています。細胞培養培地は新しい革新的なワクチンの開発をサポートするため、製薬企業やバイオテクノロジー企業が重要なユーザーとなっています。この技術は、動物実験に関連する倫理的な懸念に対処し、動物で行われる従来のワクチン試験に代わる実行可能な選択肢を提供します。細胞培養培地は、調査プロセスにおける動物犠牲の必要性を排除することで、より人道的なソリューションを提供します。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 特許分析
• バリューチェーン分析
• サプライチェーン分析
• 価格分析
• 貿易分析
• 規制情勢
• 顧客と購買基準の分析

細胞培養培地市場：タイプ別

• 無血清培地
  • CHO培地
  • HEK 293培地
  • BHK培地
  • VERO細胞培地
  • 無血清幹細胞培地
  • 免疫細胞培地
  • 昆虫細胞培地
  • その他の無血清培地
• 従来の培地と塩
• 幹細胞培養培地
• 化学的に定義された（CD）培地
• 専門培地
• その他細胞培養培地

細胞培養培地市場：用途別

• 市場概要
• バイオ医薬品製造
  • モノクローナル抗体の生産
  • ワクチン製造
  • その他の治療用タンパク質製造用途
• 診断
• 組織工学と再生医療
  • 細胞・遺伝子治療
  • その他の組織工学および再生医療の応用
• 医薬品のスクリーニングと開発
• その他の用途

細胞培養培地市場：エンドユーザー別

• 市場概要
• 製薬・バイオテクノロジー企業
• 病院および診断研究所
• 研究・学術機関
• その他のエンドユーザー

細胞培養培地市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Thermo Fischer Scientific
• Merck KGAA
• Danaher
• Sartorius AG
• Corning Incorporated
• Fujifilm Holdings Corporation
• Lonza
• Becton, Dickinson And Company（BD）
• Stemcell Technologies
• Miltenyi Biotec
• Himedia Laboratories
• Biologos
• Promocell Gmbh
• Invivogen
• Pan-Biotech
• Cellular Technology Limited
• Cyagen Biosciences
• Biowest
• Akron Biotech
• Kcell Biosciences

Global Cell Culture Media Market size was valued at USD 5.2 billion in 2022 and is poised to grow from USD 6.23 billion in 2023 to USD 20.45 billion by 2031, growing at a CAGR of 16.02% during the forecast period (2024-2031).

The market is projected to grow in the future due to the rise of new communicable diseases. Pharmaceutical and biotechnology companies are significant users of cell culture media, as it supports the development of new and innovative vaccines. This technology provides a viable alternative to traditional vaccine trials conducted on animals, addressing ethical concerns associated with animal testing. Cell culture media offers a more humane solution by eliminating the need for animal sacrifice in the research process.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Culture Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Culture Media Market Segmental Analysis

Global Cell Culture Media Market is segmented by Type, Application, End User and Region. Based on Type , the market is segmented into Serum-Free Media (CHO Media, HEK 293 Media, BHK Media, VERO Cell Media, Serum-Free Stem Cell Media, Immune Cell Media, Insect Cell Media, Other Serum-Free Media), Classical Media & Salts, Stem Cell Culture Media, Chemically Defined (CD) Media, Specialty Media, Other Cell Culture Media. Based on Application, the market is segmented into Biopharmaceutical Production (Monoclonal Antibody Production, Vaccine Production, Other Therapeutic Protein Production Applications), Diagnostics, Tissue Engineering & Regenerative Medicine (Cell & Gene Therapy, Other Tissue Engineering & Regenerative Medicine Applications), Drug Screening & Development, Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Cell Culture Media Market

The recent pandemic has accelerated market growth significantly. Cell culture media have become crucial for producing and testing new vaccines and medicines. Over the past few years, the expansion of biotechnology and pharmaceutical companies has driven increased demand for cell culture media, which are essential for developing innovative vaccines and medicines. The rise in stringent safety regulations for vaccines and efforts to curb the spread of communicable diseases have led researchers to increasingly rely on cell culture media for testing and trials.

Restraints in the Global Cell Culture Media Market

Cell culture media predominantly uses plastic materials, which accumulate over time and contribute to significant waste. Plastics are not easily degradable and, when incinerated, release harmful gases. Many countries are imposing bans on plastics due to their environmental impact. Since these plastics are intended for single use only, they cannot be reused or recycled. The rising regulatory standards for cell culture media are further driving up product costs at an accelerated pace.

Market Trends of the Global Cell Culture Media Market

Regenerative medicine represents an innovative and rapidly growing field focused on developing therapies to replace or repair damaged tissues and organ systems within the human body. This field leverages a combination of cells, biomaterials, and molecules to restore bodily structures affected by injury or disease. As these therapies depend on specialized cell culture media to support their development and application, the increasing demand for regenerative medicine is anticipated to significantly drive the growth of the cell culture media market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Patent Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Pricing Analysis
• Trade Analysis
• Regulatory Landscape
• Customer & Buying Criteria Analysis

Cell Culture Media Market, By Type

• Serum-Free Media
  • CHO Media
  • HEK 293 Media
  • BHK Media
  • VERO Cell Media
  • Serum-Free Stem Cell Media
  • Immune Cell Media
  • Insect Cell Media
  • Other Serum-Free Media
• Classical Media & Salts
• Stem Cell Culture Media
• Chemically Defined (CD) Media
• Specialty Media
• Other Cell Culture Media

Cell Culture Media Market, By Application

• Market Overview
• Biopharmaceutical Production
  • Monoclonal Antibody Production
  • Vaccine Production
  • Other Therapeutic Protein Production Applications
• Diagnostics
• Tissue Engineering & Regenerative Medicine
  • Cell & Gene Therapy
  • Other Tissue Engineering & Regenerative Medicine Applications
• Drug Screening & Development
• Other Applications

Cell Culture Media Market, By End User

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Other End Users

Cell Culture Media Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fischer Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson And Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Himedia Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biologos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promocell Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invivogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pan-Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellular Technology Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biowest
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akron Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kcell Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments